KR20120107076A - 산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도 - Google Patents

산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도 Download PDF

Info

Publication number
KR20120107076A
KR20120107076A KR1020127012599A KR20127012599A KR20120107076A KR 20120107076 A KR20120107076 A KR 20120107076A KR 1020127012599 A KR1020127012599 A KR 1020127012599A KR 20127012599 A KR20127012599 A KR 20127012599A KR 20120107076 A KR20120107076 A KR 20120107076A
Authority
KR
South Korea
Prior art keywords
compound
group
cooch
butyl
formula
Prior art date
Application number
KR1020127012599A
Other languages
English (en)
Korean (ko)
Inventor
삼패쓰 파타사라씨
Original Assignee
인베이스크 테라퓨틱스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 인베이스크 테라퓨틱스, 인크. filed Critical 인베이스크 테라퓨틱스, 인크.
Priority claimed from PCT/US2010/024772 external-priority patent/WO2010096677A2/en
Publication of KR20120107076A publication Critical patent/KR20120107076A/ko

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/08Sulfenic acids; Derivatives thereof
    • C07C313/18Sulfenamides
    • C07C313/36Sulfenamides having nitrogen atoms of sulfenamide groups further bound to other hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
KR1020127012599A 2010-02-19 2010-02-19 산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도 KR20120107076A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/024772 WO2010096677A2 (en) 2009-02-17 2010-02-19 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
KR20120107076A true KR20120107076A (ko) 2012-09-28

Family

ID=45774361

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127012599A KR20120107076A (ko) 2010-02-19 2010-02-19 산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도

Country Status (6)

Country Link
JP (1) JP2013507325A (ja)
KR (1) KR20120107076A (ja)
AU (1) AU2010215871A1 (ja)
CA (1) CA2777743A1 (ja)
IL (1) IL214785A0 (ja)
RU (1) RU2012103757A (ja)

Also Published As

Publication number Publication date
CA2777743A1 (en) 2010-08-26
RU2012103757A (ru) 2013-12-20
IL214785A0 (en) 2011-11-30
AU2010215871A1 (en) 2012-11-15
JP2013507325A (ja) 2013-03-04

Similar Documents

Publication Publication Date Title
US7384976B2 (en) Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use
EP1438288B1 (en) Substituted thioacetamides
US8816122B2 (en) Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use
US5874468A (en) Brain targeted low molecular weight hydrophobic antioxidant compounds
JP2004528337A5 (ja)
WO2010124201A2 (en) Compositions and methods for treatment of cardiovascular disease
AU2009305619B2 (en) Compositions and methods for treatment of renin-angiotensin aldosterone system (RAAS)-related disorders
US20120041025A1 (en) Dihydrolipoic Acid Derivatives Comprising Nitric Oxide and Therapeutic Uses Thereof
KR20120107076A (ko) 산화질소를 포함하는 디히드로리포산 유도체 및 이의 치료적 용도
US6469064B2 (en) Materials and methods for the treatment of depression
PL207703B1 (pl) Nitrooksypochodne i ich zastosowanie
Khan et al. New 4, 6-diacetyl resorcinol mannich bases: synthesis and biological evaluation
WO2000004001A1 (fr) Piperazinones substituees et leurs applications en therapeutique
CH635844A5 (fr) Thieno(3,2-c) et thieno(2,3-c)pyridines, leur procede de preparation et leur application en therapeutique.
WO2017085733A2 (en) Improved process for the synthesis of 2, 6-xylidine and its derivatives
JP4001317B2 (ja) 新規ウレタン、それらのチオ類似体及びジチオ類似体、これらの塩、これらの化合物を含む医薬組成物並びにそれらの使用及びそれらの調製方法
CA2015626A1 (fr) Derives benzothiazolinoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2315040C1 (ru) 3-гидроксипропиламид 4,6-диметил-1н-2-оксоникотиновой кислоты, проявляющий антикоагулянтную, противовоспалительную и анальгетическую активность
US20050054676A1 (en) Materials and methods for the treatment of depression
RU2199537C1 (ru) Триазиламиды 4-арил-2-гидрокси-4-оксо-3-(2-оксо-3,4-дигидро-2h-1,4-бензоксазинил)-2-бут еновой кислоты, проявляющие противовоспалительную активность
KR100687522B1 (ko) 2,2-디메틸-3-에스테르-4-알콕시-6-알킬 아미노벤조피란 유도체를 유효성분으로 함유하는 pge2 활성에 관련된 염증질환 치료제
EP1785417A2 (en) Novel non-psychotropic cannabinoids
JP2008542262A (ja) 2,2−ジメチル−3−アルキルエテール−4−アルコキシ−6−アルキルアミノベンゾピラン化合物またはその誘導体及びそれを有効成分として含むpge2生成抑制剤

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid